Updated: Nov 14, 2019
December National Provider Data Summary
There are currently 3 Trust’s that are not reporting RTT data:
Gloucestershire Hospitals NHS Foundation Trust (RTE)
Mid Essex Hospital Services NHS Trust (RQ8)
St George's University Hospitals NHS Foundation Trust (RJ7)
As the below heatmap and graph shows, there has been a substantial deterioration in RTT performance nationally when compared to December 2017.
Waiting List Size
As the below graph demonstrates, from March 2018 to December 2018 the total waiting list size increased from 3,843,182 to 4,151,589, an increase of 308,407 (8.02%).
Below is a table showing each reporting Trusts variance in waiting list size from March 2018 to December 2018, sorted by percentage variance (please click to view the whole table).
52 Week Waiters
The below heatmap shows how the number of 52-week waiters has changed nationally, with some areas such as the South West suffering a significant increase, the East Midlands are suffering from a less significant increase and other areas such as the North are managing to reduce their number of 52-week waiters.
Below is a table showing each reporting Trust’s variance in 52-week waiters from March 2018 to December 2018, sorted by percentage variance (please click to view the whole table).
Changes to the Individual Specialties
In regard to the waiting list size of the individual specialties:
Dermatology saw the highest percentage decrease of 4.58%, as well as the high decrease in the waiting list size going from 215,948 to 206,038, a decrease of 9,910 pathways.
Trauma & Orthopaedics also saw a high decrease in the waiting list size going from 500,427 to 490,574, a decrease of 9,853 pathways (1.96%).
Gynaecology saw a high increase in the waiting list size, going from 254,198 to 258,481, an increase of 4,283 pathways (1.68%).
Other, as a single specialty saw the largest percentage increase as well as the largest increase of pathways, going from 848,339 to 857,977, an increase of 9,638 pathways (1.13%).
At the end of December 2018, 86.6% of patients waiting to start treatment (incomplete pathways) were waiting up to 18 weeks, thus not meeting the 92% standard.
The number of RTT patients waiting to start treatment at the end of December 2018 was 4.2 million patients. Of those, 2,237 patients were waiting more than 52 weeks.
For patients waiting to start treatment at the end of December 2018, the median waiting time was 7.6 weeks. The 92nd percentile waiting time was 22.7 weeks.
During December 2018, 255,761 RTT patients started admitted treatment and 933,564 started non-admitted treatment (completed pathways).